Related Experiment Video

Updated: Jun 19, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Management of nonvalvular atrial fibrillation: a comprehensive approach

Luigi Iuliano1, Antonio Di Matteo, Giuseppe Straface

  • 1Department of Internal Medicine, Unit of Vascular Medicine, Sapienza University of Rome, Rome, Italy. luigi.iuliano@uniroma1.it

Indian Journal of Medical Sciences
|October 7, 2009
PubMed

Insights

Atrial fibrillation, a common heart rhythm disorder, significantly increases stroke risk. Antithrombotic therapy is crucial for prevention, with warfarin and aspirin offering different risk-benefit profiles.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Pharmacology

Background:

  • Atrial fibrillation is the most prevalent clinical arrhythmia, linked to substantial morbidity and mortality.
  • It often remains asymptomatic until complications like ischemic stroke occur.
  • Management involves addressing arrhythmia control and thromboembolism prevention.

Purpose of the Study:

  • To review the management strategies for atrial fibrillation.
  • To emphasize the importance of antithrombotic therapy in preventing stroke.
  • To discuss the risk factors and therapeutic options for stroke prevention.

Main Methods:

  • Review of clinical practice guidelines and epidemiological data.
  • Analysis of risk factors for stroke in atrial fibrillation patients.
  • Evaluation of antithrombotic agents (warfarin, aspirin) and their associated risks.

Main Results:

  • Rate and rhythm control strategies show comparable efficacy for mortality.
  • Antithrombotic therapy is mandatory for stroke prevention in atrial fibrillation.
  • Warfarin significantly reduces stroke risk (approx. two-thirds), while aspirin offers a smaller reduction (approx. one-fifth).
  • Bleeding risk associated with anticoagulation increases with age and comorbidities.

Conclusions:

  • Antithrombotic therapy is essential for all patients with atrial fibrillation to mitigate stroke risk.
  • The choice of antithrombotic agent must balance efficacy against bleeding risk.
  • Risk stratification is key to optimizing stroke prevention in atrial fibrillation.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...